Hedge Funds Are Getting Bullish On Halozyme Therapeutics, Inc. (HALO)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Posts Tagged ‘NASDAQ:HALO’
Did Hedge Funds Make The Right Call On Halozyme Therapeutics, Inc. (HALO) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Here is What Hedge Funds Think About Halozyme Therapeutics, Inc. (HALO)
In this article you are going to find out whether hedge funds think Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a good investment right now. We like...
Is Halozyme Therapeutics (HALO) a Smart Long-term Buy?
First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below. The First Eagle Fund of America...
Halozyme Therapeutics (HALO) Stock Is Absurdly Cheap Right Now
Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below. The fund posted a return of -11.55% for the...
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Hedge Fund and Insider Trading News: Paul Tudor Jones, Ken Griffin, Anthony Scaramucci, Massar Capital, Prosperity Bancshares, Inc. (PB), MoreHalozyme Therapeutics, Inc. (HALO), and More
Exclusive: Citadel Turns 2020 Profit After Spotting Virus Risk Early (Reuters) BOSTON (Reuters) – Citadel, the Chicago-based hedge fund giant led...
Hedge Funds Are Betting On Halozyme Therapeutics, Inc. (HALO)
“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively...
is Halozyme Therapeutics, Inc. (HALO) Going To Burn These Hedge Funds?
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock. Russell...
Is Halozyme Therapeutics, Inc. (HALO) A Good Stock To Buy?
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by...
Here’s What Hedge Funds Think About Halozyme Therapeutics, Inc. (HALO) Anymore
Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock....
Hedge Funds Are Betting On Halozyme Therapeutics, Inc. (HALO)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of...
Financial Markets Snapshot: 35 Fresh Stories Telling How is it Going in the Finance World Today
1. U.S. Stock Market: “U.S. equities traded higher on Friday as concerns about Donald Trump’s presidency recede for the time being. The Dow...
Is Halozyme Therapeutics, Inc. (HALO) Worthy of Your Portfolio?
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking...
Yelp Inc (YELP) Swung To Surprising Profit; A Look at Four Other Earnings Reports
No major moves in the US stock market this Wednesday morning, as investors digest retail earnings reports and are keeping an eye on oil prices. Analysts...
Small Companies, Big Declines: Why These Stocks Tumbled Today
The markets can’t seem to catch a break in 2016; on Wednesday, all major U.S stock indexes continued to decline. Among the stocks driving the drops...
The News that Prompted Furious Trading in These 4 Stocks Today
Sientra Inc (NASDAQ:SIEN), Select Medical Holdings Corporation (NYSE:SEM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), and Micron Technology, Inc. (NASDAQ...
Hedge Funds Are Buying Halozyme Therapeutics, Inc. (HALO)
How do we determine whether Halozyme Therapeutics, Inc. (NASDAQ:HALO) makes for a good investment at the moment? We analyze the sentiment of a select...
Insiders and Hedge Funds Were Right About Halozyme Therapeutics, Inc. (HALO); Now They Are Buying More
David Cohen and Harold Levy of Iridian Asset Management have significantly increased their stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) according...
How QVT Financial Gained from Lumber Liquidators Holdings Inc (LL)’s 53% Drop in Q1
As a new filing with the Securities and Exchange Commission shows, Daniel Gold‘s QVT Financial has initiated a passive stake in Aehr Test Systems...
Sanofi SA (ADR) (SNY), Shire PLC (ADR) (SHPG): Making Sense of the Drama About Viropharma Inc (VPHM)
In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well...
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
Is it smart to be bullish on EXACT Sciences Corporation (NASDAQ:EXAS)? In the financial world, there are a multitude of gauges shareholders can use to...
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? In the eyes of many of your fellow readers, hedge funds are viewed as overrated...
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial...
Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc. (HALO), Astex Pharmaceuticals, Inc. (ASTX): Three Humongous Health-Care Stocks This Week
With August winding down, summer won’t be around much longer. Several health-care stocks still had hot days this past week, though. Here are three...
Baxter International Inc. (BAX), Halozyme Therapeutics, Inc. (HALO): This Healthcare Company Is Poised for Growth
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7....
Halozyme Therapeutics, Inc. (HALO), Viropharma Inc (VPHM): Three Horrendous Health-Care Stocks This Week
You can’t win all of the time. This week saw its fair share of losing stocks in the health-care arena. Here are three of the biggest losers of all...
Halozyme Therapeutics, Inc. (HALO): Is This Delivery-Focused Biotech a Buy?
Editor’s Note: A previous version of this article referred to rHuPH20 as Hylenex. Halozyme Therapeutics, Inc. (NASDAQ:HALO) moved higher by 25% on...
Auxilium Pharmaceuticals, Inc. (AUXL): Huge Potential For First Line Therapy For Frozen Shoulder
Editor’s Note: This article has been amended to better describe Auxilium’s drugs and pipeline prospects. Motley Fool apologizes for the inaccuracies...
Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short. Its...
Baxter International Inc. (BAX) Healthcare Stock Checkup
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year. The company’s dividend...
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) investors should be aware of a decrease in enthusiasm from smart money lately. To most market participants,...
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
Halozyme Therapeutics, Inc. (NASDAQ:HALO) has seen an increase in activity from the world’s largest hedge funds lately. To the average investor,...
Bristol Myers Squibb Co. (BMY), Gilead Sciences, Inc. (GILD), Halozyme Therapeutics, Inc. (HALO): 3 Stocks to Watch Ahead of ASCO
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment. This year’s meeting...
Should You Avoid ACADIA Pharmaceuticals Inc. (ACAD)?
Is ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a buy, sell, or hold? Money managers are in a pessimistic mood. The number of long hedge fund bets retreated...
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That’s the motto for the market as a whole so far this year, but it’s also especially applicable for a select group of stocks...
ACADIA Pharmaceuticals Inc. (ACAD): Insiders Are Dumping, Should You?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) was in 12 hedge funds’ portfolio at the end of the fourth quarter of 2012. ACAD has experienced an increase...
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock? – Merrimack Pharmaceuticals Inc (MACK), TESARO Inc (TSRO)
Halozyme Therapeutics, Inc. (NASDAQ:HALO) has seen an increase in hedge fund interest in recent months. To most stock holders, hedge funds are perceived...
3 Horrendous Health-Care Stocks This Week: Rigel Pharmaceuticals, Inc. (RIGL), Achillion Pharmaceuticals, Inc. (ACHN)
The Motley Fool’s annual April Fools’ Day joke this year focused on the “hugest bubble in history” that is set to explode. For...
Micron Technology, Inc. (MU), Pfizer Inc. (PFE): Whoa! These Stocks Outpaced the Dow
The Dow Jones Industrial Average rose by 90 points on Friday — the exact amount it fell the day before — on hopes that a deal between the...
3 Horrendous Health-Care Stocks This Week: Herbalife Ltd. (HLF), Celsion Corporation (CLSN) and More
It’s hard to believe, but the first month of 2013 has already flown by. We ended January the same way we started it: with plenty of health-care...
